These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Risedronate metal complexes potentially active against Chagas disease. Demoro B; Caruso F; Rossi M; Benítez D; Gonzalez M; Cerecetto H; Parajón-Costa B; Castiglioni J; Galizzi M; Docampo R; Otero L; Gambino D J Inorg Biochem; 2010 Dec; 104(12):1252-8. PubMed ID: 20817265 [TBL] [Abstract][Full Text] [Related]
8. Structural and analytical characterization of three hydrates and an anhydrate form of risedronate. Redman-Furey N; Dicks M; Bigalow-Kern A; Cambron RT; Lubey G; Lester C; Vaughn D J Pharm Sci; 2005 Apr; 94(4):893-911. PubMed ID: 15736193 [TBL] [Abstract][Full Text] [Related]
9. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020 [TBL] [Abstract][Full Text] [Related]
10. Three hydrates of the bisphosphonate risedronate, consisting of one molecular and two ionic structures. Gossman WL; Wilson SR; Oldfield E Acta Crystallogr C; 2003 Feb; 59(Pt 2):m33-6. PubMed ID: 12574640 [TBL] [Abstract][Full Text] [Related]